A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Luckily for you, StockStory helps you navigate which companies are truly worth holding. That said, here are three low-volatility stocks to steer clear of and a few better alternatives.
Bausch + Lomb (BLCO)
Rolling One-Year Beta: 0.84
With a nearly 170-year history dedicated to vision care and eye health innovation, Bausch + Lomb (NYSE:BLCO) develops and manufactures a comprehensive range of eye health products including contact lenses, pharmaceuticals, surgical devices, and consumer eye care solutions.
Why Are We Cautious About BLCO?
- Earnings per share have contracted by 18% annually over the last four years, a headwind for returns as stock prices often echo long-term EPS performance
- Free cash flow margin shrank by 8.4 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive
- Underwhelming 1.5% return on capital reflects management’s difficulties in finding profitable growth opportunities
At $17.35 per share, Bausch + Lomb trades at 17x forward P/E. Read our free research report to see why you should think twice about including BLCO in your portfolio.
Henry Schein (HSIC)
Rolling One-Year Beta: 0.22
With a vast inventory of over 300,000 products stocked in distribution centers spanning more than 5.3 million square feet worldwide, Henry Schein (NASDAQ:HSIC) is a global distributor of healthcare products and services primarily to dental practices, medical offices, and other healthcare facilities.
Why Is HSIC Not Exciting?
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Earnings growth over the last five years fell short of the peer group average as its EPS only increased by 3.9% annually
- Diminishing returns on capital suggest its earlier profit pools are drying up
Henry Schein’s stock price of $83.68 implies a valuation ratio of 15x forward P/E. To fully understand why you should be careful with HSIC, check out our full research report (it’s free).
Cullen/Frost Bankers (CFR)
Rolling One-Year Beta: 0.07
Tracing its roots back to 1868 when it was founded during Texas's post-Civil War reconstruction era, Cullen/Frost Bankers (NYSE:CFR) operates Frost Bank, a Texas-based financial institution providing commercial and consumer banking, wealth management, and insurance services.
Why Are We Wary of CFR?
- 7.2% annual revenue growth over the last two years was slower than its banking peers
- Earnings growth underperformed the sector average over the last two years as its EPS grew by just 10.7% annually
- Projected tangible book value per share decline of 6.3% for the next 12 months points to tough credit quality challenges ahead
Cullen/Frost Bankers is trading at $150.36 per share, or 2.1x forward P/B. Read our free research report to see why you should think twice about including CFR in your portfolio.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.